India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Adani Po 366.85 1.16
Ong Corp 159.70 3.12
Power Gr 195.85 1.26
Icici Ba 297.55 1.90
Tata Stl 558.20 0.60
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Glenmark Pharmaceutical Limited
Glenmark Pharmaceutical Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
Market Lot: 1Face Value: 1ISIN Demat: INE935A01035
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
19-Jun-2018       Glenmark Pharma gets approval for North California facility IRIS
06-Jun-2018       Glenmark Pharma gets final approval for generic Loestrin IRIS
30-May-2018       Glenmark Pharm quarterly earnings fall 17.5%  IRIS
28-May-2018       Glenmark Pharma announces poster presentations on GBR 1302 and GBR 1342 IRIS
22-May-2018       Glenmark Pharma submits Ryaltris NDA application to USFDA IRIS
21-May-2018       Glenmark Pharma gets nod for Colesevelam HCl tablets IRIS
18-May-2018       Glenmark Pharmaceuticals updates on clinical study of GBR 830 IRIS
16-May-2018       Glenmark to introduce generic Seretide Accuhaler in Denmark IRIS
11-May-2018       Glenmark Pharma receives nod for Clobetasol propionate cream IRIS
10-May-2018       Glenmark Pharma to present updated data on GBR 830 at int'l investigative dermatology meeting IRIS
20-Apr-2018       Glenmark Pharma gets final nod for Clobetasol Propionate solution IRIS
18-Apr-2018       Glenmark Pharma receives USFDA nod for Tacrolimus ointment IRIS
17-Apr-2018       Glenmark initiates phase 2b clinical trial of GBR 830 IRIS
04-Apr-2018       Glenmark Pharma and Helsinn Group enter into an exclusive licensing agreement IRIS
27-Mar-2018       Glenmark Pharma gets USFDA nod for Clobetasol spray IRIS
06-Mar-2018       Glenmark Pharma presents new data on Ryaltris IRIS
22-Feb-2018       Glenmark Pharma enters into collaboration with SDC Pharma IRIS
19-Feb-2018       Glenmark Pharma presents findings from Phase 2a study of GBR 830 IRIS
25-Jan-2018       Glenmark Pharma presents preliminary biomarker data on GBR 1302 IRIS
27-Dec-2017       Glenmark Pharma gets final nod for generic Minastrin 24 Fe tablets IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited